07:00 , Apr 21, 2014 |  BC Week In Review  |  Financial News

Heart Metabolics completes venture financing

Heart Metabolics Ltd. , London, U.K.   Business: Cardiovascular   Date completed: 4/17/14   Type: Venture financing   Raised: Not disclosed   Investors: venBio; Seroba Kernel Life Sciences; Brandon Capital Partners; AshHill Investments   Note:...
08:00 , Jan 7, 2013 |  BC Week In Review  |  Company News

Heart Metabolics board of directors update

Heart Metabolics Ltd. , London, U.K.   Business: Cardiovascular   Appointed: Michael Bettess, investment manager at Trans Tasman Commercialization Fund; Andrew O'Brien, investment advisor at Trans Tasman; and Steven Smith, secretary and general counsel at...
08:00 , Jan 7, 2013 |  BC Week In Review  |  Company News

Heart Metabolics management update

Heart Metabolics Ltd. , London, U.K.   Business: Cardiovascular   Hired: Peter Milner, president and CEO of AshHill Investments, as CEO and a director; Mary Pendergast as head of regulatory affairs and a consultant, formerly...
08:00 , Jan 7, 2013 |  BC Week In Review  |  Financial News

Heart Metabolics completes venture financing

Heart Metabolics Ltd. , London, U.K.   Business: Cardiovascular   Date completed: 1/3/13   Type: Venture financing   Raised: $4 million   Investors: Trans Tasman Commercialization Fund; AshHill Investments   Note: Heart Metabolics raised $4...
02:18 , Jan 3, 2013 |  BC Extra  |  Financial News

Heart Metabolics closes series A tranche

Heart Metabolics Ltd. (London, U.K.) raised $4 million in the first tranche of a planned $6 million series A round. Trans Tasman Commercialization Fund led the tranche, with participation from AshHill Investments. Additionally, Heart Metabolics...